Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
OSCR

OSCR - Oscar Health, Inc. Stock Price, Fair Value and News

18.98USD-0.02 (-0.11%)Delayed as of 14 Jun 2024, 10:57 am ET

Market Summary

OSCR
USD18.98-0.02
Delayedas of 14 Jun 2024, 10:57 am
-0.11%

OSCR Alerts

  • 6 major insider sales recently.
  • Big jump in Revenue (Y/Y)
  • Big jump in Earnings (Y/Y)

OSCR Stock Price

View Fullscreen

OSCR RSI Chart

OSCR Valuation

Market Cap

4.4B

Price/Earnings (Trailing)

-82.14

Price/Sales (Trailing)

0.67

EV/EBITDA

366.9

Price/Free Cashflow

-83.74

OSCR Price/Sales (Trailing)

OSCR Profitability

EBT Margin

-0.78%

Return on Equity

-5.19%

Return on Assets

-1.21%

Free Cashflow Yield

-1.19%

OSCR Fundamentals

OSCR Revenue

Revenue (TTM)

6.5B

Rev. Growth (Yr)

45.77%

Rev. Growth (Qtr)

49.64%

OSCR Earnings

Earnings (TTM)

-53.5M

Earnings Growth (Yr)

545.96%

Earnings Growth (Qtr)

218.18%

Breaking Down OSCR Revenue

52 Week Range

5.3119.33
(Low)(High)

Last 7 days

-2.6%

Last 30 days

-16.8%

Last 90 days

37.2%

Trailing 12 Months

107.9%

How does OSCR drawdown profile look like?

OSCR Financial Health

Current Ratio

1.16

Debt/Equity

0.29

Debt/Cashflow

-0.18

OSCR Investor Care

Shares Dilution (1Y)

6.70%

Diluted EPS (TTM)

-0.42

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20246.5B000
20234.5B5.0B5.4B5.9B
20222.4B2.9B3.4B4.0B
20211.9B2.2B2.4B1.8B
20201.2B1.4B1.5B1.7B
20190001.0B

Tracking the Latest Insider Buys and Sells of Oscar Health, Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jun 06, 2024
robinson elbert o. jr.
acquired
-
-
8,974
-
Jun 06, 2024
boyd jeffery h
acquired
-
-
8,974
-
Jun 06, 2024
blackley richard scott
sold
-586,969
19.58
-29,978
chief financial officer
Jun 06, 2024
wittman vanessa ames
acquired
-
-
8,974
-
Jun 06, 2024
gassen william
acquired
-
-
8,974
-
Jun 06, 2024
lang laura w
acquired
-
-
8,974
-
Jun 06, 2024
plouffe david
acquired
-
-
8,974
-
Jun 06, 2024
quane alessandrea c.
sold
-328,807
19.58
-16,793
evp, chief insurance officer
Jun 05, 2024
quane alessandrea c.
acquired
-
-
31,250
evp, chief insurance officer
Jun 05, 2024
blackley richard scott
acquired
-
-
62,500
chief financial officer

1–10 of 50

Which funds bought or sold OSCR recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 11, 2024
EverSource Wealth Advisors, LLC
reduced
-31.17
4,797
20,444
-%
May 24, 2024
FARALLON CAPITAL MANAGEMENT LLC
new
-
163,570
163,570
-%
May 22, 2024
Beck Bode, LLC
new
-
9,856,390
9,856,390
2.01%
May 16, 2024
8 KNOTS MANAGEMENT, LLC
sold off
-100
-2,255,310
-
-%
May 16, 2024
SkyView Investment Advisors, LLC
new
-
149,000
149,000
0.03%
May 16, 2024
COMERICA BANK
added
205
3,443
4,312
-%
May 16, 2024
JANE STREET GROUP, LLC
added
156
3,355,140
4,416,790
-%
May 16, 2024
Tidal Investments LLC
sold off
-100
-127,569
-
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-4.26
724,428
2,027,520
-%
May 15, 2024
RBF Capital, LLC
unchanged
-
2,571,730
6,685,610
0.37%

1–10 of 44

Are Funds Buying or Selling OSCR?

Are funds buying OSCR calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own OSCR
No. of Funds

Unveiling Oscar Health, Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
dragoneer investment group, llc
6.7%
12,725,999
SC 13G
Feb 14, 2024
general catalyst group management holdings gp, llc
1.1%
2,107,719
SC 13G/A
Feb 14, 2024
khosla ventures iv, l.p.
2.4%
4,564,404
SC 13G/A
Feb 13, 2024
vanguard group inc
7.47%
14,244,912
SC 13G/A
Feb 12, 2024
flynn james e
5.89%
11,246,820
SC 13G/A
Feb 02, 2024
capitalg 2015 lp
0.0%
0
SC 13G/A
Jan 26, 2024
blackrock inc.
7.5%
14,351,597
SC 13G/A
Jan 10, 2024
southeastern asset management inc/tn/
3.0%
571
SC 13G/A
Dec 01, 2023
flynn james e
5.52%
10,537,491
SC 13G
Feb 14, 2023
southeastern asset management inc/tn/
8.1%
145
SC 13G/A

Recent SEC filings of Oscar Health, Inc.

View All Filings
Date Filed Form Type Document
Jun 11, 2024
8-K
Current Report
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 07, 2024
8-K
Current Report
Jun 07, 2024
4
Insider Trading
Jun 07, 2024
4
Insider Trading

Peers (Alternatives to Oscar Health, Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
457.7B
379.5B
-3.22% 8.59%
29.8
1.21
12.96% -25.81%
94.9B
206.0B
-3.57% 26.64%
24.62
0.46
12.55% -43.95%
89.3B
66.7B
6.37% 20.20%
16.32
1.34
9.59% -4.59%
76.6B
360.9B
8.98% -8.43%
10.46
0.21
9.07% 78.83%
36.8B
155.5B
-10.29% 6.67%
13.46
0.24
6.34% 84.42%
12.6B
14.7B
5.13% 28.66%
15.49
0.86
7.99% 19.23%
12.5B
12.3B
3.74% 45.80%
15.28
1.01
5.77% 58.74%
MID-CAP
8.1B
2.3B
-5.45% -0.01%
28.73
3.55
5.96% 18.29%
6.2B
3.0B
-7.01% -9.23%
-544.71
2.06
10.92% -104.06%
2.2B
1.5B
-5.59% 23.35%
34.9
1.5
19.34% 40.15%
2.0B
3.5B
-13.69% -50.16%
14.21
0.59
-27.67% -62.40%
SMALL-CAP
1.9B
1.1B
5.75% 24.78%
28.95
1.75
11.45% 30.74%
1.3B
3.0B
-6.99% 58.71%
-7.38
0.42
4.98% 4.88%
53.7M
-
-1.46% -24.54%
-3.55
-
- -1.05%
20.7M
21.6M
-7.10% 23.86%
40.75
0.96
9.04% -57.88%

Oscar Health, Inc. News

Latest updates
MarketBeat20 hours ago
Defense World26 hours ago
Defense World12 Jun 202411:08 am
MarketBeat11 Jun 202408:07 pm

Oscar Health, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Revenue49.6%2,142,305,0001,431,658,0001,439,991,0001,521,535,0001,469,685,000995,127,000978,427,0001,017,319,000972,765,000823,112,500673,460,000723,927,000610,099,000439,846,000414,505,000393,540,000424,448,000-
  S&GA Expenses729.9%394,162,000-62,574,50075,503,00076,453,000398,519,00075,808,00078,557,00080,754,00074,664,00089,337,00060,003,00051,166,00064,572,00062,276,00036,546,00035,994,00031,839,000-
EBITDA Margin102.8%0.00-0.04-0.05-0.09-0.12-0.14-0.16-0.20-0.23-0.30-0.22-0.19-0.20-0.23-0.17-0.19-0.21-0.24
Interest Expenses-5.1%5,902,0006,217,0006,130,0006,120,0006,136,0006,135,0006,126,0006,141,0004,221,000397,000398,000228,0003,697,0003,514,000----
Income Taxes223.6%996,000-806,000915,0001,164,0002,021,000-715,000-1,615,000290,0001,517,000-111,000-597,000589,000965,000-481,000-998,0001,593,000931,000-
Earnings Before Taxes218.5%178,478,000-150,644,000-64,788,000-14,261,000-37,607,000-227,275,000-195,162,000-111,835,000-75,803,000-197,852,000-212,078,000-72,734,000-87,916,000-190,351,000-80,130,000-39,351,000-95,948,000-
EBT Margin82.8%-0.01-0.05-0.06-0.10-0.13-0.15-0.17-0.21-0.24-0.31-0.23-0.20-0.21-0.24-0.17-0.19-0.22-0.25
Net Income218.2%177,368,000-150,081,500-65,398,000-15,425,000-39,772,000-224,981,500-192,913,000-112,125,000-77,320,000-198,921,000-211,481,000-73,323,000-88,881,000-189,870,000-79,132,000-40,944,000-96,879,000-
Net Income Margin82.3%-0.01-0.05-0.06-0.10-0.13-0.15-0.17-0.21-0.24-0.31-0.23-0.20-0.21-0.24-0.17-0.19-0.22-0.25
Free Cashflow113.7%634,363,000296,868,000-1,149,266,000165,524,000414,715,000151,394,000-548,361,000214,467,000562,849,00034,479,000-589,252,00055,337,000317,691,00088,983,000-218,923,000246,322,000106,350,000-
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q4
Assets22.7%4,4193,6013,3504,5654,4834,5274,3094,7514,3513,3223,1703,7063,5942,272
  Current Assets14.5%3,5043,0612,9924,1934,1314,1223,9314,2603,6752,3062,2412,8163,1791,870
    Cash Equivalents19.3%2,2311,8701,4002,3222,1101,5802,1132,3632,0691,1041,0771,6722,321843
  Net PPE-0.8%61.0062.0062.0063.0064.0060.0056.0051.0049.0047.0043.0041.0039.0036.00
Liabilities21.1%3,3852,7952,4283,6133,5513,6343,2243,5033,0151,9291,6171,9731,8081,823
  Current Liabilities24.3%3,0192,4292,0613,2443,1823,2642,8533,1302,6411,8521,6171,9731,8081,666
  Long Term Debt0.1%299299299298298298298298297----142
    LT Debt, Non Current0.1%299299299298298298298298297----142
Shareholder's Equity28.4%1,0328049199529328921,0851,2481,3351,3931,5531,7321,785-
  Retained Earnings6.2%-2,699-2,876-2,726-2,661-2,645-2,605-2,379-2,187-2,074-1,999-1,800-1,587-1,514-1,427
  Additional Paid-In Capital1.5%3,7373,6823,6543,6213,5833,5093,4793,4503,4223,3943,3563,3243,303133
Shares Outstanding4.4%23122222321921721221221121117916920789.0029.00
Minority Interest5.3%2.002.002.002.002.002.003.003.003.005.00----
Float----1,500---728---3,386--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Cashflow From Operations113.7%634297-1,149166415151-54821456334.00-58955.0031889.00-218246106-
  Share Based Compensation-0.8%26.0026.0029.0033.0071.0029.0029.0027.0028.0028.0021.0018.0019.0014.007.007.008.00-
Cashflow From Investing-274.3%-30017222544.00136-70629979.00103-19.84-12.36-708-34.2815.00-43326.0048.00-
Cashflow From Financing2454.6%27.001.002.003.001.001.000.001.0029913.0011.003.001,2123851.002250.00-
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

OSCR Income Statement

2024-03-31
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue  
Premium$ 2,093,682$ 1,428,626
Investment income42,98936,056
Services and other5,6345,003
Total revenue2,142,3051,469,685
Operating Expenses  
Medical1,554,7741,091,592
Selling, General and Administrative Expense394,162398,519
Depreciation and amortization7,8114,939
Total operating expenses1,956,7471,495,050
Earnings (loss) from operations185,558(25,365)
Interest expense5,9026,136
Other expenses1,1786,106
Earnings (loss) before income taxes178,478(37,607)
Income tax expense9962,021
Net income (loss)177,482(39,628)
Less: Net income attributable to noncontrolling interests114144
Net income (loss) attributable to Oscar Health, Inc.$ 177,368$ (39,772)
Earnings (Loss) per Share  
Basic (in dollars per share)$ 0.77$ (0.18)
Diluted (in dollars per share)$ 0.62$ (0.18)
Weighted average common shares outstanding, basic (in shares)231,443,000216,913,000
Weighted-average common shares outstanding, diluted (in shares)293,796,000216,913,000

OSCR Balance Sheet

2024-03-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current Assets:  
Cash and cash equivalents$ 2,230,799$ 1,870,315
Short-term investments616,134689,833
Premiums and accounts receivable (net of allowance for credit losses of $30,600 and $31,600)342,904201,269
Risk adjustment transfer receivable62,03751,925
Reinsurance recoverable242,935241,194
Other current assets8,9836,564
Total current assets3,503,7923,061,100
Property, equipment, and capitalized software, net61,40661,930
Long-term investments736,624365,309
Restricted deposits29,81429,870
Other assets87,21783,271
Total assets4,418,8533,601,480
Current Liabilities:  
Benefits payable1,248,347965,986
Risk adjustment transfer payable1,336,0221,056,941
Premium deficiency reserve4,3325,776
Unearned premiums65,54165,918
Accounts payable and other liabilities303,245273,367
Reinsurance payable61,93861,024
Total current liabilities3,019,4252,429,012
Long-term debt298,972298,777
Other liabilities66,16967,574
Total liabilities3,384,5662,795,363
Commitments and contingencies (Note 12)
Stockholders' Equity  
Treasury stock (315 thousand shares as of March 31, 2024 and December 31, 2023)(2,923)(2,923)
Additional paid-in capital3,736,8853,682,294
Accumulated deficit(2,699,347)(2,876,715)
Accumulated other comprehensive income (loss)(2,594)1,309
Total Oscar Health, Inc. stockholders' equity1,032,023803,967
Noncontrolling interests2,2642,150
Total stockholders' equity1,034,287806,117
Total liabilities and stockholders' equity4,418,8533,601,480
Class A  
Stockholders' Equity  
Common stock22
Class B  
Stockholders' Equity  
Common stock$ 0$ 0
OSCR
Oscar Health, Inc. operates as a health insurance in the United States. The company offers Individual and Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payors directly enable their shift to value-based care It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
 CEO
 WEBSITEhioscar.com
 INDUSTRYHealthcare Plans
 EMPLOYEES2714

Oscar Health, Inc. Frequently Asked Questions


What is the ticker symbol for Oscar Health, Inc.? What does OSCR stand for in stocks?

OSCR is the stock ticker symbol of Oscar Health, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Oscar Health, Inc. (OSCR)?

As of Thu Jun 13 2024, market cap of Oscar Health, Inc. is 4.4 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of OSCR stock?

You can check OSCR's fair value in chart for subscribers.

What is the fair value of OSCR stock?

You can check OSCR's fair value in chart for subscribers. The fair value of Oscar Health, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Oscar Health, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for OSCR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Oscar Health, Inc. a good stock to buy?

The fair value guage provides a quick view whether OSCR is over valued or under valued. Whether Oscar Health, Inc. is cheap or expensive depends on the assumptions which impact Oscar Health, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for OSCR.

What is Oscar Health, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Jun 13 2024, OSCR's PE ratio (Price to Earnings) is -82.14 and Price to Sales (PS) ratio is 0.67. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. OSCR PE ratio will change depending on the future growth rate expectations of investors.